Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Politics & Policy

German parliament passes new drug pricing rules

November 16, 2010 1:14 AM UTC

Germany's parliament passed healthcare reform legislation last week that will introduce a new drug pricing system. Under the rules, companies will set the price of a new drug in the first year following its launch. Within a year of launch, the Federal Joint Committee and health technology assessment agency IQWiG will conduct a technology appraisal to determine the drug's cost-effectiveness and whether it provides an added benefit.

If a drug provides additional clinical benefit, then the drug's manufacturer and the insurance company association would negotiate a price. However, if a drug does not demonstrate an added benefit, it is added to the reference pricing system, which gives the same base price to comparable drugs. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article